Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ENGNW

enGene Therapeutics Inc.

CIK 0001980845 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.43
↑ 0.18 (71.90%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$28.81M
P/E Ratio
-0.23
EPS
2.29
Dividend Yield
Not covered
52W Position
8%
Beta
3.27

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.11
P/S
Not covered
EV/Revenue
Not covered
ROE
-49.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 8%
$0.11$4.20

Latest Financials

2025-10-31 FY
Revenue
–
Net Income
-$117.30M
Total Assets
$221.47M
Free Cash Flow
-$100.72M

Recent news